Investigation of the effect of the angiotensin II type 2 receptor (AT2R) agonist C21 on plasma NT-proBNP a diagnostic biomarker, in subjects hospitalised with COVID-19

Category Primary study
ConferenceEuropean Heart Journal
Year 2022
This article has no abstract
Epistemonikos ID: 8d46d7eea2495798757d3a2e8769f8014eb1dae1
First added on: Feb 15, 2025